High rate of event-free survival at 24 months with everolimus/ RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Research output: Contribution to journalLetterpeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'High rate of event-free survival at 24 months with everolimus/ RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)'. Together they form a unique fingerprint.